CD4 and cancer: The high ART usage rate and the median CD4 count also support thehypothesis that referrals to cancer treatment favor patients with previouslydiagnosed HIV who are already engaged in care, or possibly those patients whocaregivers felt were more likely to benefit from cancer therapy.